
About Uas Pharmaceuticals (India) Private Limited
Data last updated:
Uas Pharmaceuticals (India) Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Uas Pharmaceuticals Pty Ltd. It operates in the health and beauty retail and distribution segment of the consumer goods sector. It was incorporated on 20 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2007PTC214233. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Ajit Kumar Seth and Anuj Seth.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at A 9 Lsc Sarai Rohilla Padam Nagar, New Delhi, Delhi, India – 110007.
As per the financials filed for FY 2019, the company reported a revenue of ₹1.86 Cr. For the same year it recorded a net loss of ₹1.44 Cr (net margin -77.5%) and EBITDA of -₹1.43 Cr (EBITDA margin -76.8%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 3% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
Court records list 6 cases involving the company, including 3 filed by the company and 3 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website uaspharma.in.
Company details
CIN history
Uas Pharmaceuticals (India) has one previous CIN (Corporate Identification Number): U51397TN2007PTC062782. The current CIN is U51397DL2007PTC214233, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51397DL2007PTC214233 | Current |
| U51397TN2007PTC062782 | Previous |
Contact details
Uas Pharmaceuticals (India) Private Limited's registered office is in New Delhi, Delhi. Its website is uaspharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA 9 Lsc Sarai Rohilla Padam Nagar, New Delhi, Delhi, India – 110007
- IndustryConsumer Goods, Health & Beauty Retail & Distribution
To see the full contact details of Uas Pharmaceuticals (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Uas Pharmaceuticals (India) are trade and support service to organizations. In detail, this covers wholesale trading and other support services to organizations. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Uas Pharmaceuticals (India) Private Limited, buy the company report.
Financials of Uas Pharmaceuticals (India) Private Limited
FY 2019 filings availableUas Pharmaceuticals (India) Private Limited reported revenue of ₹1.86 Cr for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.86 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.43 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.44 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -76.8% | ||||
| Net Profit Margin | -77.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Uas Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of Uas Pharmaceuticals (India) Private Limited
Uas Pharmaceuticals (India) has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashi Dayal | Additional Director | 31 Mar 2015 | 11 Years 7 Months | Current |
| Ajit Kumar Seth | Director | 20 Mar 2007 | 19 Years 7 Months | Current |
| Anuj Seth | Director | 09 Jun 2009 | 17 Years 5 Months | Current |
| Urvashi Seth | Director | 20 Mar 2007 | 19 Years 7 Months | Current |
Peer comparison
Uas Pharmaceuticals (India) Private Limited is compared with the 6 companies closest to it by revenue in the Consumer Products industry (Health and Beauty Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pashupati Chemicals & Pharmaceuticals Limited | ₹1.87 Cr (FY 2024) | -23.0% | Kolkata, West Bengal, India | |||
| Frankfurt Pharmaceuticals Private Limited | ₹1.87 Cr (FY 2025) | 10.0% | New Delhi, Delhi, India | |||
| Astorion Pharmaceuticals Private Limited | ₹1.87 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India | |||
| Leewell Pharmaceuticals Private Limited | ₹1.86 Cr (FY 2025) | 94.0% | Hyderabad, Telangana, India | |||
| Uas Pharmaceuticals (India) Private Limitedthis company | ₹1.86 Cr (FY 2019) | -₹1.44 Cr | -77.5% | 9 | New Delhi, Delhi, India | |
| Catholicon Pharmaceuticals Private Limited | ₹1.86 Cr (FY 2025) | -19.0% | Chandigarh, India | |||
| Precise Pharmaceuticals Private Limited | ₹1.85 Cr (FY 2024) | 7.0% | Ludhiana, Punjab, India |
To see the full peer comparison of Uas Pharmaceuticals (India) Private Limited, buy the company report.
Auditor
Uas Pharmaceuticals (India) Private Limited is audited by H U M S & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H U M S & ASSOCIATES | FY 2019 | 022230N |
Shareholding
The shareholding of Uas Pharmaceuticals (India) Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Uas Pharmaceuticals (India) Private Limited, buy the company report.
Legal cases
Uas Pharmaceuticals (India) Private Limited has 6 court cases on record: 3 filed by Uas Pharmaceuticals (India), 3 filed against it. 1 case is pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 3 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Court case (MCA DJ) | Filed by the company against Altas Logistics Private Limited | Disposed |
| District court, South East, Delhi | Civil suit | Filed against the company by Atlas Logistics Pvt Ltd | Disposed |
| High Court of Delhi | Court case (CM(M)) | Filed by the company against M/S Atlas Logistics Pvt Ltd | Disposed |
| District court, Allahabad, Uttar Pradesh | Civil suit | Filed against the company by an individual | Pending |
| District court, Central, Delhi | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Uas Pharmaceuticals (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Uas Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Uas Pharmaceuticals (India) Private Limited has a workforce of 9 employees on its EPFO records as of Feb 2020, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2019-20 | 9 |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Uas Pharmaceuticals (India) Private Limited, buy the company report.
GST
Uas Pharmaceuticals (India) has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Uas Pharmaceuticals (India) Private Limited, buy the company report.
Recent activity
Uas Pharmaceuticals (India) Private Limited has 7 board changes on record since 2007: 4 appointments and 3 cessations. The latest: Neha Dayal ceased to be Director on 18 Aug 2017.
Frequently asked questions
Uas Pharmaceuticals (India) is an active private limited company based in New Delhi, Delhi, India. The company works in health and beauty retail and distribution, within the consumer goods industry. It was incorporated on 20 March 2007 (19+ years old) and is registered under CIN U51397DL2007PTC214233.
Uas Pharmaceuticals (India) has 4 current directors:
- Ashi Dayal - Additional Director
- Ajit Kumar Seth - Director
- Anuj Seth - Director
- Urvashi Seth - Director
The latest financial statements of Uas Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Uas Pharmaceuticals (India) has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Uas Pharmaceuticals (India) is U51397DL2007PTC214233. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Uas Pharmaceuticals (India) has 6 court cases on record: 3 filed by the company and 3 filed against it. 1 is pending. Most are in the district courts.
Uas Pharmaceuticals (India) was incorporated on 20 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Uas Pharmaceuticals (India) by revenue are Pashupati Chemicals & Pharmaceuticals Limited, Frankfurt Pharmaceuticals Private Limited, Astorion Pharmaceuticals Private Limited, Leewell Pharmaceuticals Private Limited, Catholicon Pharmaceuticals Private Limited and 1 more, all in the Consumer Products industry (Health and Beauty Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Neha Dayal ceased to be Director on 18 Aug 2017. Ashi Dayal ceased to be Additional Director on 24 Aug 2015. Ashi Dayal was appointed as Additional Director on 31 Mar 2015. Uas Pharmaceuticals (India) has 7 board changes on record in total.
Uas Pharmaceuticals (India) can be reached through the website uaspharma.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Uas Pharmaceuticals (India) is at A 9 Lsc Sarai Rohilla Padam Nagar, New Delhi, Delhi, India – 110007.

